CATL Shares Fall as Hungary Plant Faces Safety Halt 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO 
OpenAI Rejects Apple Trade Secret Theft Claims 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
Milei Threatens Falkland Oil Firms With Sanctions 
Add as a preferred source on Google
HORSHAM, Pa., March 06, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that its fourth quarter and fiscal 2017 financial results earnings call has been delayed to March 29th. The call has been delayed because additional time is required, due in part to an extended power outage at the Company’s Horsham, PA facility, to complete the company's review of certain accounting matters.
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
| Investor Contacts: | ||
| Frank McCaney, Chief Executive Officer STRATA Skin Sciences, Inc. 215-619-3200 [email protected] | Bob Yedid, Managing Director LifeSci Advisors, LLC 646-597-6989 [email protected] |
